Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 18 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

18 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
March 14, 2025 LYEL P 158,000 $0.60 $94,800 843,365 Indirect +23.05% Acquired -26.7% (price as of 2026-10-06)
Aug. 15, 2023 LYEL S 58,020 $2.28 $132,286 930,880 Indirect -5.87% Disposed -80.7% (price as of 2026-10-06)
Sept. 23, 2022 LYEL S 11,100 $6.40 $71,040 988,900 Indirect -1.11% Disposed -93.1% (price as of 2026-10-06)
Nov. 13, 2015 ILMN S 10b5-1 730 $163.52 $119,370 23,100 Direct -3.06% Disposed 72.0% (price as of 2026-10-06)
Sept. 28, 2015 ILMN S 10b5-1 423 $173.20 $73,264 24,016 Direct -1.73% Disposed 62.4% (price as of 2026-10-06)
March 10, 2015 ILMN S 10b5-1 1,186 $191.75 $227,416 24,948 Direct -4.54% Disposed 46.6% (price as of 2026-10-06)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 10, 2026 LYEL Option (right to buy) Common Stock (9,250) $13.22 June 9, 2036 9,250 Acquired
June 9, 2026 PBLS Stock Option (Right to Buy) Common Stock (20,215) $20.00 June 8, 2036 20,215 Acquired
May 15, 2025 LYEL Option (right to buy) Common Stock (130,000) $0.40 May 14, 2035 130,000 Acquired
June 14, 2024 LYEL Option (right to buy) Common Stock (130,000) $2.36 June 13, 2034 130,000 Acquired
Sept. 8, 2023 LYEL Option (right to buy) [F2] Common Stock (55,000) $3.19 Sept. 7, 2033 55,000 Acquired
June 16, 2023 LYEL Option (right to buy) Common Stock (65,000) $3.19 June 15, 2033 65,000 Acquired
June 8, 2022 LYEL Option (right to buy) Common Stock (65,000) $5.31 June 7, 2032 65,000 Acquired
June 21, 2021 LYEL Series A Convertible Preferred Stock Common Stock (3,765,842) · · 3,765,842 Disposed
Dec. 5, 2014 ILMN Performance Shares Common Stock (5,925) · Dec. 31, 2017 5,925 Acquired
Jan. 29, 2014 ILMN Performance Shares Common Stock (7,032) · Jan. 1, 2017 7,032 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 8 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
June 9, 2026 PBLS Stock Option (right to buy)→ Common Stock (21,273) 21,273 Direct
June 9, 2026 PBLS Stock Option (right to buy)→ Common Stock (48,736) 48,736 Direct
June 16, 2021 LYEL Common Stock 2,967,834 Direct
June 16, 2021 LYEL Option (right to buy)→ Common Stock (2,713,756) 2,713,756 Direct
June 16, 2021 LYEL Option (right to buy)→ Common Stock (650,000) 650,000 Direct
June 16, 2021 LYEL Option (right to buy)→ Common Stock (4,675,392) 4,675,392 Direct
June 16, 2021 LYEL Series A Convertible Preferred Stock→ Common Stock (3,765,842) 3,765,842 Indirect
Nov. 6, 2013 ILMN Common Stock 22,570 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2014 $403,692 · $2,875,388 · $315,700 · $76,233 $3,671,013

LYEL

M.D. Board Chair and former Executive Chairman
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2021 $253,549 $222,007 $10,908,331 $21,948,133 · · $34,609 $33,366,629

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.